Opendata, web and dolomites

BREATH

BREATH: Biomarkers for Respiratory diseases detected in Exhaled Air through a new Technological instrument for research and Healthcare markets.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BREATH project word cloud

Explore the words cloud of the BREATH project. It provides you a very rough idea of what is the project "BREATH" about.

air    feasibility    stages    assessing    diagnose    detect    fundamentally    patients    initially    responsible    biomarkers    stage    difficult    health    small    healthcare    easily    painful    economic    reliability    diagnostic    respiratory    quality    faster    instrument    academia    asthma    exhaled    phase1    commercial    provides    breath    chronic    companies    patient    completely    each    million    consists    kits    disease    alone    extensive    checking    substantial    professionals    380    pharmaceutical    socio    innovation    lung    collect    once    breathing    repeatable    device    actively    diagnosis    market    diagnosed    risk    outcome    quantitative    time    chemical    manufacture    designing    usually    pexa    profitability    services    disposable    particles    pulmonary    service    stand    diseases    brings    figure    billion    cancer    clients    alternative    obstructive    burden    airways    invasive    deaths    prove    competitiveness    tuberculosis   

Project "BREATH" data sheet

The following table provides information about the project.

Coordinator
PEXA AB 

Organization address
address: ERIK DAHLBERGSGATAN 11 A
city: GOTEBORG
postcode: 411 26
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Project website http://pexa.se/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.4. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-11-01   to  2017-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PEXA AB SE (GOTEBORG) coordinator 50˙000.00

Map

 Project objective

Each year in Europe, lung diseases are responsible of more than one million deaths and extensive costs estimated at €380 billion. These respiratory diseases, such as chronic obstructive pulmonary disease, lung cancer, asthma and tuberculosis, are very difficult to detect and usually diagnosed in late-stages once there is a significant burden of disease within them. BREATH project consists to develop, manufacture and market a research instrument to study and to diagnose respiratory diseases. The concept is based on a completely new method to collect and analyse particles via exhaled air in the small airways to easily identify chemical changes and potential biomarkers for respiratory diseases. The PExA method has the potential to fundamentally change the way lung diseases are diagnosed and treated today by offering a best alternative of the existing methods on market, which brings a substantial commercial potential. By doing a simple breathing test and without any potential risk for the patients, PExA's instrument provides a quantitative, reliable, user friendly, non-invasive, less painful, faster, repeatable method for early-stage diagnosis. PExA's clients are all those who are currently actively looking for biomarkers to figure out the patient's health conditions such as lung researchers and healthcare professionals within health services, academia and pharmaceutical companies initially in the EU and then the US. The objectives of BREATH project Phase1 are to: (1) prove through a feasibility study the potential to develop a real-time and stand-alone analysis/diagnostic device; (2) enhance the competitiveness and profitability of the service by improving the quality and reliability of the system via (i) the checking system, (ii) designing and developing our own disposable kits. The outcome will be a feasibility study assessing the socio-economic, commercial and technical aspects of the innovation that will be used to define the activities of Phase II.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BREATH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BREATH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.4.;H2020-EU.2.3.1.)

FlexiBiome (2018)

Next Generation Microbiome Platform

Read More  

N-IF (2017)

The N-IF mouse – a new and unique fibrosis model for preclinical efficacy studies

Read More  

SEQURE (2018)

Targeted complete next-generation sequencing for companion diagnostics and personalized treatment of cancer

Read More